vs

Side-by-side financial comparison of DILLARD'S, INC. (DDS) and Teradyne (TER). Click either name above to swap in a different company.

DILLARD'S, INC. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.1× Teradyne). Teradyne runs the higher net margin — 31.1% vs 8.8%, a 22.3% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 2.9%). Over the past eight quarters, Teradyne's revenue compounded faster (32.6% CAGR vs -16.9%).

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.

DDS vs TER — Head-to-Head

Bigger by revenue
DDS
DDS
1.1× larger
DDS
$1.5B
$1.3B
TER
Growing faster (revenue YoY)
TER
TER
+84.1% gap
TER
87.0%
2.9%
DDS
Higher net margin
TER
TER
22.3% more per $
TER
31.1%
8.8%
DDS
Faster 2-yr revenue CAGR
TER
TER
Annualised
TER
32.6%
-16.9%
DDS

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
DDS
DDS
TER
TER
Revenue
$1.5B
$1.3B
Net Profit
$129.8M
$398.9M
Gross Margin
43.4%
60.9%
Operating Margin
11.5%
36.9%
Net Margin
8.8%
31.1%
Revenue YoY
2.9%
87.0%
Net Profit YoY
4.2%
EPS (diluted)
$8.31
$2.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DDS
DDS
TER
TER
Q1 26
$1.3B
Q4 25
$1.5B
$1.1B
Q3 25
$1.5B
$769.2M
Q2 25
$1.5B
$651.8M
Q1 25
$2.0B
$685.7M
Q4 24
$1.4B
$752.9M
Q3 24
$1.5B
$737.3M
Q2 24
$1.5B
$729.9M
Net Profit
DDS
DDS
TER
TER
Q1 26
$398.9M
Q4 25
$129.8M
$257.2M
Q3 25
$72.8M
$119.6M
Q2 25
$163.8M
$78.4M
Q1 25
$214.4M
$98.9M
Q4 24
$124.6M
$146.3M
Q3 24
$74.5M
$145.6M
Q2 24
$180.0M
$186.3M
Gross Margin
DDS
DDS
TER
TER
Q1 26
60.9%
Q4 25
43.4%
57.2%
Q3 25
36.6%
58.4%
Q2 25
43.9%
57.2%
Q1 25
34.9%
60.6%
Q4 24
42.6%
59.4%
Q3 24
37.6%
59.2%
Q2 24
44.6%
58.3%
Operating Margin
DDS
DDS
TER
TER
Q1 26
36.9%
Q4 25
11.5%
27.1%
Q3 25
6.2%
18.9%
Q2 25
14.0%
13.9%
Q1 25
11.7%
17.6%
Q4 24
11.4%
20.4%
Q3 24
6.5%
20.6%
Q2 24
15.2%
28.8%
Net Margin
DDS
DDS
TER
TER
Q1 26
31.1%
Q4 25
8.8%
23.7%
Q3 25
4.8%
15.5%
Q2 25
10.7%
12.0%
Q1 25
10.6%
14.4%
Q4 24
8.7%
19.4%
Q3 24
5.0%
19.8%
Q2 24
11.6%
25.5%
EPS (diluted)
DDS
DDS
TER
TER
Q1 26
$2.53
Q4 25
$8.31
$1.62
Q3 25
$4.66
$0.75
Q2 25
$10.39
$0.49
Q1 25
$13.41
$0.61
Q4 24
$7.73
$0.89
Q3 24
$4.59
$0.89
Q2 24
$11.09
$1.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DDS
DDS
TER
TER
Cash + ST InvestmentsLiquidity on hand
$1.1B
$241.9M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$2.0B
Total Assets
$4.3B
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DDS
DDS
TER
TER
Q1 26
$241.9M
Q4 25
$1.1B
$293.8M
Q3 25
$1.0B
$272.7M
Q2 25
$900.5M
$339.3M
Q1 25
$717.9M
$475.6M
Q4 24
$980.4M
$553.4M
Q3 24
$946.7M
$510.0M
Q2 24
$817.8M
$421.9M
Total Debt
DDS
DDS
TER
TER
Q1 26
$0
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
DDS
DDS
TER
TER
Q1 26
Q4 25
$2.0B
$2.8B
Q3 25
$1.9B
$2.7B
Q2 25
$1.9B
$2.8B
Q1 25
$1.8B
$2.8B
Q4 24
$2.0B
$2.8B
Q3 24
$1.9B
$2.9B
Q2 24
$1.9B
$2.7B
Total Assets
DDS
DDS
TER
TER
Q1 26
$4.4B
Q4 25
$4.3B
$4.2B
Q3 25
$3.7B
$4.0B
Q2 25
$3.9B
$3.8B
Q1 25
$3.5B
$3.7B
Q4 24
$4.1B
$3.7B
Q3 24
$3.7B
$3.8B
Q2 24
$3.9B
$3.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DDS
DDS
TER
TER
Operating Cash FlowLast quarter
$186.5M
$265.1M
Free Cash FlowOCF − Capex
$156.2M
FCF MarginFCF / Revenue
10.6%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
1.44×
0.66×
TTM Free Cash FlowTrailing 4 quarters
$781.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DDS
DDS
TER
TER
Q1 26
$265.1M
Q4 25
$186.5M
$281.6M
Q3 25
$86.8M
$49.0M
Q2 25
$232.6M
$182.1M
Q1 25
$364.7M
$161.6M
Q4 24
$173.5M
$282.6M
Q3 24
$-68.4M
$166.3M
Q2 24
$244.4M
$216.1M
Free Cash Flow
DDS
DDS
TER
TER
Q1 26
Q4 25
$156.2M
$218.8M
Q3 25
$60.1M
$2.4M
Q2 25
$215.8M
$131.7M
Q1 25
$349.3M
$97.6M
Q4 24
$145.4M
$225.2M
Q3 24
$-94.3M
$114.4M
Q2 24
$209.2M
$171.2M
FCF Margin
DDS
DDS
TER
TER
Q1 26
Q4 25
10.6%
20.2%
Q3 25
4.0%
0.3%
Q2 25
14.1%
20.2%
Q1 25
17.3%
14.2%
Q4 24
10.2%
29.9%
Q3 24
-6.3%
15.5%
Q2 24
13.5%
23.5%
Capex Intensity
DDS
DDS
TER
TER
Q1 26
Q4 25
2.1%
5.8%
Q3 25
1.8%
6.1%
Q2 25
1.1%
7.7%
Q1 25
0.8%
9.3%
Q4 24
2.0%
7.6%
Q3 24
1.7%
7.0%
Q2 24
2.3%
6.1%
Cash Conversion
DDS
DDS
TER
TER
Q1 26
0.66×
Q4 25
1.44×
1.09×
Q3 25
1.19×
0.41×
Q2 25
1.42×
2.32×
Q1 25
1.70×
1.63×
Q4 24
1.39×
1.93×
Q3 24
-0.92×
1.14×
Q2 24
1.36×
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons